Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of post-traumatic stress disorder. It is the first such decision issued on a psychedelic drug application.

The Conversation

FDA approves 1st needle-free alternative to EpiPens

There's now an option to treat anaphylaxis via a nasal spray, rather than with an auto-injected medication.

LiveScience

Tim Walz Is Another Big-Government Liberal

Plus: A listener asks the editors about tariffs and subsidies in the manufacture of electric vehicles.

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Blue-Chip Dividend Stocks for a Secure Retirement Portfolio

Blue-chip dividend stocks are of well-established companies offering steady income and financial stability. They are ideal for securing a resilient retirement portfolio, combining consistent dividends with potential capital appreciation. Thus, quality blue-chip dividend stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and McDonald’s (MCD) could be ideal portfolio additions for retirement…

StockNews.com

FDA Declines To Approve MDMA-Assisted Psychotherapy As a PTSD Treatment

The FDA, which approved the protocols for the studies it now questions, is asking for an additional Phase 3 clinical trial, which would take years and millions of dollars.

Reason

FDA rejects MDMA therapy for treatment of PTSD. What’s next? - Roll Call

The Food and Drug Administration declined to approve MDMA as the first psychedelic drug used to treat post-traumatic stress disorder.

Roll Call

Neffy: Know All About First FDA Approved Nasal Spray To Treat Severe Allergic Reactions

The new treatment, a needle-free alternative, could be used for managing severe allergic responses in children and adults, weighing at least 66 pounds, the FDA said.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

JD Vance Supports State Decision-Making On Abortion Policy

JD Vance supports state autonomy in abortion policy, advocating for varied regulations based on state decisions.

Top News

FDA Approves Needle-Free Nasal Spray For Severe Allergic Reactions

FDA approves Neffy, a needle-free nasal spray epinephrine for anaphylaxis treatment, providing a convenient and effective option for severe allergic reactions.

Top News

FDA Declines Approval For MDMA As PTSD Treatment

FDA declines approval for MDMA as PTSD treatment, citing safety and efficacy concerns. Further trials needed.

Top News

FDA won't approve psychedelic MDMA for PTSD, calling for additional study

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD

The Independent UK

Home medical devices pose risks for Medicare beneficiaries and their caregivers

From infusion pumps to nebulizers, home medical equipment comes with potential problems for users.

Fortune

FDA Approves New Immunotherapy Drug For Endometrial Cancer Patients

FDA approves Jemperli for endometrial cancer, revolutionizing treatment options with immunotherapy. Keytruda and Imfinzi expand personalized therapies.

Top News

Kamala Harris' Campaign Criticizes Trump Over Abortion Pill Comments

President Trump's consideration of revoking access to the abortion pill mifepristone sparks debate on reproductive rights and access to abortion in the US.

Top News

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

Lawsuits Filed Against Abbott Nutrition Over Infant Formula Contamination

Lawsuit filed against Abbott Nutrition over tainted infant formula linked to baby's death, raising awareness about powdered formula risks.

The Independent UK

After baby's death, Kentucky parents sue infant formula maker at center of 2022 crisis

The parents of Kentucky baby who died last fall after drinking bacteria-tainted infant formula are the latest to sue manufacturer Abbott Nutrition

Reason

Kamala Harris Is Running on 'Freedom.' Does She Mean More Than Just Abortion?

Gov. Tim Walz, the vice presidential candidate, told Republicans to "mind your own damn business" about abortion policy. Perhaps they should apply that concept further.

The Times of India

This anti-ageing supplement is going viral among Hollywood's elite; is it safe for your health?

Anti-ageing biohacking is the latest health trend that's fast gaining popularity among America's wellness fraternity. The promise to reverse age and defy related conditions indeed looks magical and pathbreaking. Nicotinamide adenine dinucleotide (NAD) supplements, a coenzyme form of niacin (Vitamin B3) have shown promise with its wonderful properties in DNA…

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Diet Mountain Dew for the win? Why the favorite soda of both JD Vance and Tim Walz may not be a health drink.

The chartreuse soda contains three artificial sweeteners and various additives. How safe are they?

Fortune

Denmark gets Novo Nordisk to lower Ozempic prices

As Congress pushes for Medicare to cover anti-obesity drugs, puzzlement remains about who should get them, for how long, and at what price.

Fortune

Nara Smith TikTok DIY sunscreen causes more harm than good

As homemade sunscreen formulations are trending across social media, experts warn they are doing more harm than good.

Salon

The FDA and psychedelic research

To move the drugs forward, manufacturers may need to follow the agency’s advice for elevating evidence quality

International Business Times

The Dangerous Side Of Healthcare: Selling Unregulated Devices And Increasing Patient Risk

According to the FDA's guidance document on when to submit a 510(k) for changes to an existing device, manufacturers must submit a new 510(k) if there are significant changes to the device's design, materials, or intended use.

StockNews.com

3 Biotech Stocks With Anticipated Strong Earnings Reports

With highly effective drugs and treatment options, chronic disease prevalence, and adoption of technology, the biotech market is thriving. Hence, fundamentally solid biotech stocks Illumina (ILMN), Amgen (AMGN), and Entrada Therapeutics (TRDA) could be ideal with anticipated strong earnings reports. Read more.

The Guardian - US

Project 2025: what does the rightwing blueprint say about abortion?

Policy playbook developed for potential Trump 2.0 term aims to ban abortion pills, increase surveillance and champion fetal personhood

1 … 96 97 98 99

People

Julie Chavez Rodriguez

25 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

214 stories

Novo

181 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.